A carregar...
AXL Mediates TRAIL Resistance in Esophageal Adenocarcinoma
The overexpression of AXL receptor tyrosine kinase is a frequent finding that has been associated with poor prognosis in esophageal adenocarcinoma (EAC). As the majority of EAC are intrinsically resistant to DNA-damaging therapies, an alternative therapeutic approach based on the activation of death...
Na minha lista:
Main Authors: | , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Neoplasia Press Inc.
2013
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3593152/ https://ncbi.nlm.nih.gov/pubmed/23479507 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|